Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Levitzki

Showing results (71-80 of 93) with videos related to

Pageof 10
Sort By:
Biochemistry|August 7, 2002
Toward a PKB inhibitor: modification of a selective PKA inhibitor by rational designHadas Reuveni, Nurit Livnah, Tamar Geiger, et al.
Growth Factors (Chur, Switzerland)|March 20, 2014
EGF receptor family: twisting targets for improved cancer therapiesAntony W Burgess, Yoav I Henis, Nancy E Hynes, et al.
Oncotarget|April 28, 2017
PSMA-homing dsRNA chimeric protein vector kills prostate cancer cells and activates anti-tumor bystander responsesYael Langut, Nufar Edinger, Efrat Flashner-Abramson, et al.
Experimental and Molecular Pathology|June 5, 2003
Tyrphostin AG-556 reduces myocardial infarct size and improves cardiac performance in the ratJacob George, Simon Biner, Pnina Keren, et al.
Bioorganic & Medicinal Chemistry|November 1, 2011
Tyrphostin-like compounds with ubiquitin modulatory activity as possible therapeutic agents for multiple myelomaZhenghong Peng, Ashutosh Pal, Dongmei Han, et al.
Molecular Cancer Therapeutics|October 1, 2014
The tyrphostin NT157 suppresses insulin receptor substrates and augments therapeutic response of prostate cancerNaokazu Ibuki, Mazyar Ghaffari, Hadas Reuveni, et al.
Cancer Research|May 9, 2013
Therapeutic destruction of insulin receptor substrates for cancer treatmentHadas Reuveni, Efrat Flashner-Abramson, Lilach Steiner, et al.
Molecular Cancer Therapeutics|February 15, 2018
Impact of the Anticancer Drug NT157 on Tyrosine Kinase Signaling NetworksShih-Ping Su, Efrat Flashner-Abramson, Shoshana Klein, et al.
Bioconjugate Chemistry|August 15, 2014
Optimization of liganded polyethylenimine polyethylene glycol vector for nucleic acid deliverySalim Joubran, Maya Zigler, Neta Pessah, et al.
Biomaterials|July 28, 2004
Locally delivered nanoencapsulated tyrphostin (AGL-2043) reduces neointima formation in balloon-injured rat carotid and stented porcine coronary arteriesShmuel Banai, Michael Chorny, S David Gertz, et al.
Pageof 10

Showing results (71-80 of 93) with videos related to

Sort By:
Pageof 10
Biochemistry|August 7, 2002
Toward a PKB inhibitor: modification of a selective PKA inhibitor by rational designHadas Reuveni, Nurit Livnah, Tamar Geiger, et al.
Growth Factors (Chur, Switzerland)|March 20, 2014
EGF receptor family: twisting targets for improved cancer therapiesAntony W Burgess, Yoav I Henis, Nancy E Hynes, et al.
Oncotarget|April 28, 2017
PSMA-homing dsRNA chimeric protein vector kills prostate cancer cells and activates anti-tumor bystander responsesYael Langut, Nufar Edinger, Efrat Flashner-Abramson, et al.
Experimental and Molecular Pathology|June 5, 2003
Tyrphostin AG-556 reduces myocardial infarct size and improves cardiac performance in the ratJacob George, Simon Biner, Pnina Keren, et al.
Bioorganic & Medicinal Chemistry|November 1, 2011
Tyrphostin-like compounds with ubiquitin modulatory activity as possible therapeutic agents for multiple myelomaZhenghong Peng, Ashutosh Pal, Dongmei Han, et al.
Molecular Cancer Therapeutics|October 1, 2014
The tyrphostin NT157 suppresses insulin receptor substrates and augments therapeutic response of prostate cancerNaokazu Ibuki, Mazyar Ghaffari, Hadas Reuveni, et al.
Cancer Research|May 9, 2013
Therapeutic destruction of insulin receptor substrates for cancer treatmentHadas Reuveni, Efrat Flashner-Abramson, Lilach Steiner, et al.
Molecular Cancer Therapeutics|February 15, 2018
Impact of the Anticancer Drug NT157 on Tyrosine Kinase Signaling NetworksShih-Ping Su, Efrat Flashner-Abramson, Shoshana Klein, et al.
Bioconjugate Chemistry|August 15, 2014
Optimization of liganded polyethylenimine polyethylene glycol vector for nucleic acid deliverySalim Joubran, Maya Zigler, Neta Pessah, et al.
Biomaterials|July 28, 2004
Locally delivered nanoencapsulated tyrphostin (AGL-2043) reduces neointima formation in balloon-injured rat carotid and stented porcine coronary arteriesShmuel Banai, Michael Chorny, S David Gertz, et al.
Pageof 10